MetaCap

Aspire-Lakewood (ASBP) vs Biofrontera (BFRI)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Aspire-Lakewood (ASBP) has outperformed Biofrontera (BFRI) over the past year, gaining 83.8% versus a loss of 28.4%. Aspire-Lakewood is the larger company by market cap ($10.0 million vs $9.5 million), about 1.1 times the size. Biofrontera converts more of its revenue into profit, with a net margin of -25.3% versus -394725.1%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ASBP+83.76%BFRI-28.38%
+150%+21%-108%
Nov 21, 20251 yearNov 20, 2026
ASBP-98.22%BFRI-99.37%
+36%-35%-106%
Apr 11, 20225 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ASBP versus BFRI key metrics
MetricASBPBFRI
Share price$7.13$0.53
Market cap$10.00M$9.51M
1-day change-5.44%-7.02%
YTD return+35.04%-7.02%
1-year return+83.76%-28.38%
5-year return—-99.66%
Forward P/E—1.32
EPS (TTM)$-30.89$-0.26
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$6.20K$41.70M
Revenue growth (YoY)—+11.75%
Net income (latest FY)$-24.48M$-10.54M
Gross margin-1.87%—
Operating margin-312016.95%-27.21%
Net margin-394725.06%-25.26%
52-week high$9.50$1.66
52-week low$0.11$0.53
Distance from 52-week high-24.95%-68.07%
Analyst consensus—none
Avg. price target upside—+1032.08%
Average volume29.24K429.04K
Shares outstanding1.40M17.95M
Employees—84
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • ASBP has outperformed BFRI by 112.1 percentage points over the past year.
  • Biofrontera is more profitable, keeping -25.3 cents of every revenue dollar as net income versus -394725.1 cents for Aspire-Lakewood.

About Aspire-Lakewood

ASBP stock →

Aspire-Lakewood Holdings, Inc. develops sublingual drug delivery technology and manufactures automotive and industrial control systems.

Health Care · Biotechnology: Pharmaceutical Preparations

About Biofrontera

BFRI stock →

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions.

Health Care · Biotechnology: Pharmaceutical Preparations · 84 employees

ASBP vs BFRI FAQ

Which is bigger, Aspire-Lakewood or Biofrontera?

Aspire-Lakewood (ASBP) is larger, with a market capitalization of $10.00M compared with $9.51M for Biofrontera (BFRI).

Which stock has performed better over the past year, ASBP or BFRI?

ASBP returned +83.76% over the past 12 months, compared with -28.38% for BFRI (price return, excluding dividends). Past performance does not predict future results.

Are Aspire-Lakewood and Biofrontera in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons